A seguir

Reprodução automática

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 Visualizações • 07/14/23
Compartilhar
Embutir
administrator
administrator
Assinantes
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

Mostre mais
0 Comentários sort Ordenar por
Comentários do Facebook

A seguir

Reprodução automática